Spinobulbar muscular atrophy (Kennedy's disease)

Handbook of Clinical Neurophysiology

Volumn 4, Issue C, 2004, Pages 403-417

  Gallo, Jean Marc ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77957038383     PISSN: 15674231     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-4231(04)04023-7     Document Type: Article

References (101)

1. Abel A., Walcott J., Woods J., Duda J., and Merry D.E. Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice. Hum. Mol. Genet 10 (2001) 107-116
2. Adachi H., Katsuno M., Minamiyama M., Sang C., Pagoulatos G., Angelidis C., Kusakabe M., Yoshiki A., Kobayashi Y., Doyu M., and Sobue G. Heat shock protein 70 chaperone overexpression ameliorates phenotypes of the spinal and bulbar muscular atrophy transgenic mouse model by reducing nuclear-localized mutant androgen receptor protein. J. Neurosci 23 (2003) 2203-2211
3. Antonini G., Gragnani F., Romaniello A., Pennisi E.M., Morino S., Ceschin V., Santoro L., and Cruccu G. Sensory involvement in spinal-bulbar muscular atrophy (Kennedy's disease). Muscle Nerve 23 (2000) 252-258
4. Bailey C.K., Andriola I.F., Kampinga H.H., and Merry D.E. Molecular chaperones enhance the degradation of expanded polyglutamine repeat androgen receptor in a cellular model of spinal and bulbar muscular atrophy. Hum. Mol. Genet 11 (2002) 515-523
5. Bentel J.M., and Tilley W.D. Androgen receptors in prostate cancer. J. Endocrinol 151 (1996) 1-11
6. Biancalana V., Serville F., Pommier J., Julien J., Hanauer A., and Mandel J.L. Moderate instability of the trinucleotide repeat in spino bulbar muscular atrophy. Hum. Mol. Genet 1 (1992) 255-258
7. Bingham P.M., Scott M.O., Wang S., McPhaul M.J., Wilson E.M., Garbern J.Y., Merry D.E., and Fischbeck K.H. Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice. Nat. Genet 9 (1995) 191-196
8. Bruening W., Roy J., Giasson B., Figlewicz D.A., Mushynski W.E., and Durham H.D. Up-regulation of protein chaperones preserves viability of cells expressing toxic Cu/Zn-superoxide dismutase mutants associated with amyotrophic lateral sclerosis. J. Neurochem 72 (1999) 693-699
9. Bruijn L.I., Houseweart M.K., Kato S., Anderson K.L., Anderson S.D., Ohama E., Reaume A.G., Scott R.W., and Cleveland D.W. Aggregation and motor neuron toxicity of an ALS-linked SOD1 mutant independent from wild-type SOD1. Science 281 (1998) 1851-1854
10. Butler R., Leigh P.N., McPhaul M.J., and Gallo J.-M. Truncated forms of the androgen receptor are associated with polyglutamine expansion in X-linked spinal and bulbar muscular atrophy. Hum. Mol. Genet 7 (1998) 121-127
11. Butler R., Leigh P.N., and Gallo J.-M. Androgen-induced up-regulation of tubulin isoforms in neuroblastoma cells. J. Neurochem 78 (2001) 854-861
12. Chamberlain N.L., Driver E.D., and Miesfeld R.L. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acid Res 22 (1994) 3181-3186
13. Cummings C.J., Mancini M.A., Antalffy B., DeFranco D.B., Orr H.T., and Zoghbi H.Y. Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nat. Genet 19 (1998) 148-154
14. Cummings C.J., Sun Y., Opal P., Antalffy B., Mestril R., Orr H.T., Dillmann W.H., and Zoghbi H.Y. Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum. Mol. Genet 10 (2001) 1511-1518
15. Danek A., Witt T.N., Mann K., Schweikert H.U., Romalo G., La Spada A.R., and Fischbeck K.H. Decrease in androgen binding and effect of androgen treatment in a case of X-linked bulbospinal neuronopathy. Clin. Investig 72 (1994) 892-897
16. Darrington R.S., Butler R., Leigh P.N., McPhaul M.J., and Gallo J.-M. Ligand-dependent aggregation of polyglutamine-expanded androgen receptor in neuronal cells. Neuroreport 13 (2002) 2117-2120
17. Davies S.W., Turmaine M., Cozens B.A., DiFiglia M., Sharp A.H., Ross C.A., Scherzinger E., Wanker E.E., Mangiarini L., and Bates G.P. Formation of neuronal inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation. Cell 90 (1997) 537-548
18. Dejager S., Bry-Gauillard H., Bruckert E., Eymard B., Salachas F., LeGuern E., Tardieu S., Chadarevian R., Giral P., and Turpin G. A comprehensive endocrine description of Kennedy's disease revealing androgen insensitivity linked to CAG repeat length. J. Clin. Endocrinol. Metab 87 (2002) 3893-3901
19. DiFiglia M., Sapp E., Chase K.O., Davies S.W., Bates G.P., Vonsattel J.P., and Aronin N. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277 (1997) 1990-1993
20. Doyu M., Sobue G., Mukai E., Kachi T., Yasuda T., Mitsuma T., and Takahashi A. Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann. Neurol 32 (1992) 707-710
21. Eisen A. Clinical electrophysiology of the upper and lower motor neuron in amyotrophic lateral sclerosis. Semin. Neurol 21 (2001) 141-145
22. Ferrante M.A., and Wilbourn A.J. The characteristic electrodiagnostic features of Kennedy's disease. Muscle Nerve 20 (1997) 323-329
23. Gallo J.-M., and Anderton B.H. Ubiquitous variations in nerves. Nature 337 (1989) 687-688
24. Goldenberg J.N., and Bradley W.G. Testosterone therapy and the pathogenesis of Kennedy's disease (X-linked bulbospinal muscular atrophy). J. Neurol. Sci 135 (1996) 158-161
25. Griffin J.E. Androgen resistance - the clinical and molecular spectrum. N. Engl. J. Med 326 (1992) 611-618
26. Hafezparast M., Klocke R., Ruhrberg C., Marquardt A., Ahmad-Annuar A., Bowen S., Lalli G., Witherden A.S., Hummerich H., Nicholson S., Morgan P.J., Oozageer R., Priestley J.V., Averill S., King V.R., Ball S., Peters J., Toda T., Yamamoto A., Hiraoka Y., Augustin M., Korthaus D., Wattler S., Wabnitz P., Dickneite C., Lampel S., Boehme F., Peraus G., Popp A., Rudelius M., Schlegel J., Fuchs H., de Angelis M.H., Schiavo G., Shima D.T., Russ A.P., Stumm G., Martin J.E., and Fisher E.M. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science 300 (2003) 808-812
27. Harding A.E., Thomas P.K., Baraitser M., Bradbury P.G., Morgan-Hughes J.A., and Pongsford J.R. X-linked recessive bulbospinal neuronopathy: a report of ten cases. J. Neurol. Neurosurg. Psychiatry 45 (1982) 1012-1019
28. Heinlein C.A., and Chang C. Androgen receptor (AR) coregulators: an overview. Endocrinol. Rev 23 (2002) 175-200
29. Hochstrasser M. Ubiquitin-dependent protein degradation. Annu. Rev. Genet 30 (1996) 405-439
30. Hockly E., Richon V.M., Woodman B., Smith D.L., Zhou X., Rosa E., Sathasivam K., Ghazi-Noori S., Mahal A., Lowden P.A., Steffan J.S., Marsh J.L., Thompson L.M., Lewis C.M., Marks P.A., and Bates G.P. Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease. Proc. Natl Acad. Sci. USA 100 (2003) 2041-2046
31. Hirota N., Eisen A., and Weber M. Complex fasciculations and their origin in amyotrophic lateral sclerosis and Kennedy's disease. Muscle Nerve 23 (2000) 1872-1875
32. Hsiao P.W., Lin D.L., Nakao R., and Chang C. The linkage of Kennedy's neuron disease to ARA24, the first identified androgen receptor polyglutamine region-associated coactivator. J. Biol. Chem 274 (1999) 20229-20234
33. Huang C.C., Chen R.S., Chu N.S., Cheng C.C., Pang C.Y., and Wei Y.H. X-linked recessive bulbospinal neuronopathy: clinical and molecular studies in a Taiwanese family. J. Formos. Med. Assoc 97 (1998) 354-359
34. Igarashi S., Tanno Y., Onodera O., Yamazaki M., Sato S., Ishikawa A., Miyatani N., Nagashima M., Ishikawa Y., Sahashi K., Ibi T., Miyatake T., and Tsuji S. Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy. Neurology 42 (1992) 2300-2302
35. Ishihara H., Kanda F., Nishio H., Sumino K., and Chihara K. Clinical features and skewed X-chromosome inactivation in female carriers of X-linked recessive spinal and bulbar muscular atrophy. J. Neurol 248 (2001) 856-860
36. Jones K.J. Androgenic enhancement of motor neuron regeneration. Ann. NY Acad. Sci 743 (1994) 141-161
37. Jones K.J., and Oblinger M.M. Androgenic regulation of tubulin gene expression in axotomized hamster facial motoneurons. J. Neurosci 14 (1994) 3620-3627
38. Julien J.-P., and Mushynski W.E. Neurofilaments in health and disease. Prog. Nucleic Acid Res. Mol. Biol 61 (1998) 1-23
39. Kato S., Hayashi H., Nakashima K., Nanba E., Kato M., Hirano A., Nakano I., Asayama K., and Ohama E. Pathological characterization of astrocytic hyaline inclusions in familial amyotrophic lateral sclerosis. Am. J. Pathol 151 (1997) 611-620
40. Katsuno M., Adachi H., Kume A., Li M., Nakagomi Y., Niwa H., Sang C., Kobayashi Y., Doyu M., and Sobue G. Testosterone reduction prevents phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Neuron 35 (2002) 843-854
41. Katsuno M., Adachi H., Doyu M., Minamiyama M., Sang C., Kobayashi Y., Inukai A., and Sobue G. Leuprorelin rescues polyglutamine-dependent phenotypes in a transgenic mouse model of spinal and bulbar muscular atrophy. Nat. Med 9 (2003) 768-773
42. n-expanded neuronopathies. Hum. Mol. Genet 4 (1995) 523-527
43. Kennedy W.R., Alter M., and Sung J.H. Progressive proximal spinal and bulbar muscular atrophy of late onset: a sex-linked recessive trait. Neurology 18 (1968) 671-680
44. Klement I.A., Skinner P.J., Kaytor M.D., Yi H., Hersch S.M., Clark H.B., Zoghbi H.Y., and Orr H.T. Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95 (1998) 41-53
45. Kujawa K.A., Kinderman N.B., and Jones K.J. Testosterone-induced acceleration of recovery from facial paralysis following crush axotomy of the facial nerve in male hamsters. Exp. Neurol 105 (1989) 80-85
46. Kujawa K.A., Emeric E., and Jones K.J. Testosterone differentially regulates the regenerative properties of injured hamster facial motoneurons. J. Neurosci 11 (1991) 3898-3906
47. La Spada A.R., Wilson E.M., Lubahn D.B., Harding A.E., and Fischbeck K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352 (1991) 77-79
48. La Spada A.R., Roling D.B., Harding A.E., Warner C.L., Spiegel R., Hausmanowa-Petrusewicz I., Yee W.C., and Fischbeck K.H. Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat. Genet 2 (1992) 301-304
49. La Spada A.R., Peterson K.R., Meadows S.A., McClain M.E., Jeng G., Chmelar R.S., Haugen H.A., Chen K., Singer M.J., Moore D., Trask B.J., Fischbeck K.H., Clegg C.H., and McKnight G.S. Androgen receptor YAC transgenic mice carrying CAG 45 alleles show trinucleotide repeat instability. Hum. Mol. Genet 7 (1998) 959-967
50. La Spada A.R., Fu Y.H., Sopher B.L., Libby R.T., Wang X., Li L.Y., Einum D.D., Huang J., Possin D.E., Smith A.C., Martinez R.A., Koszdin K.L., Treuting P.M., Ware C.B., Hurley J.B., Ptacek L.J., and Chen S. Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron 31 (2001) 913-927
51. LaMonte B.H., Wallace K.E., Holloway B.A., Shelly S.S., Ascano J., Tokito M., Van Winkle T., Howland D.S., and Holzbaur E.L. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration. Neuron 34 (2002) 715-727
52. Leigh P.N., Anderton B.H., Dodson A., Gallo J.-M., Swash M., and Power D.M. Ubiquitin deposits in anterior horn cells in motor neurone disease. Neurosci. Lett 93 (1988) 197-203
53. Leigh P.N., Dodson A., Swash M., Brion J.P., and Anderton B.H. Cytoskeletal abnormalities in motor neuron disease. An immunocytochemical study. Brain 112 (1989) 521-535
54. Li M., Sobue G., Doyu M., Mukai E., Hashizume Y., and Mitsuma T. Primary sensory neurons in X-linked recessive bulbospinal neuropathy: histopathology and androgen receptor gene expression. Muscle Nerve 18 (1995) 301-308
55. Li M., Miwa S., Kobayashi Y., Merry D.E., Yamamoto M., Tanaka F., Doyu M., Hashizume Y., Fischbeck K.H., and Sobue G. Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy. Ann. Neurol 44 (1998) 249-254
56. Li M., Nakagomi Y., Kobayashi Y., Merry D.E., Tanaka F., Doyu M., Mitsuma T., Hashizume Y., Fischbeck K.H., and Sobue G. Nonneuronal nuclear inclusions of androgen receptor protein in spinal and bulbar muscular atrophy. Am. J. Pathol 153 (1998) 695-701
57. Li J.L., Hayden M.R., Almqvist E.W., Brinkman R.R., Durr A., Dode C., Morrison P.J., Suchowersky O., Ross C.A., Margolis R.L., Rosenblatt A., Gomez-Tortosa E., Cabrero D.M., Novelletto A., Frontali M., Nance M., Trent R.J., McCusker E., Jones R., Paulsen J.S., Harrison M., Zanko A., Abramson R.K., Russ A.L., Knowlton B., Djousse L., Mysore J.S., Tariot S., Gusella M.F., Wheeler V.C., Atwood L.D., Cupples L.A., Saint-Hilaire M., Cha J.H., Hersch S.M., Koroshetz W.J., Gusella J.F., MacDonald M.E., and Myers R.H. A genome scan for modifiers of age at onset in Huntington disease: The HD MAPS study. Am. J. Hum. Genet 73 (2003) 682-687
58. Lieberman A.P., Harmison G., Strand A.D., Olson J.M., and Fischbeck K.H. Altered transcriptional regulation in cells expressing the expanded polyglutamine androgen receptor. Hum. Mol. Genet 11 (2002) 1967-1976
59. Lin X., Antalffy B., Kang D., Orr H.T., and Zoghbi H.Y. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat. Neurosci 3 (2000) 157-163
60. Lou J.S., Valls-Sole J., Toro C., and Hallett M. Facial action myoclonus in patients with olivopontocerebellar atrophy. Mov. Disord 9 (1994) 223-226
61. Lowe J., Lennox G., Jefferson D., Morrell K., McQuire D., Gray T., Landon M., Doherty F.J., and Mayer R.J. A filamentous inclusion body within anterior horn neurones in motor neurone disease defined by immunocytochemical localisation of ubiquitin. Neurosci. Lett 94 (1988) 203-210
62. Luthi-Carter R., Strand A., Peters N.L., Solano S.M., Hollingsworth Z.R., Menon A.S., Frey A.S., Spektor B.S., Penney E.B., Schilling G., Ross C.A., Borchelt D.R., Tapscott S.J., Young A.B., Cha J.H., and Olson J.M. Decreased expression of striatal signaling genes in a mouse model of Huntington's disease. Hum. Mol. Genet 9 (2000) 1259-1271
63. MacLean H.E., Choi W.T., Rekaris G., Warne G.L., and Zajac J.D. Abnormal androgen receptor binding affinity in subjects with Kennedy's disease (spinal and bulbar muscular atrophy). J. Clin. Endocrinol. Metab 80 (1995) 508-516
64. MacLean H.E., Warne G.L., and Zajac J.D. Localization of functional domains in the androgen receptor. J. Steroid Biochem. Mol. Biol 62 (1997) 233-242
65. McCampbell A., Taylor J.P., Taye A.A., Robitschek J., Li M., Walcott J., Merry D., Chai Y., Paulson H., Sobue G., and Fischbeck K.H. CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet 9 (2000) 2197-2202
66. McCampbell A., Taye A.A., Whitty L., Penney E., Steffan J.S., and Fischbeck K.H. Histone deacetylase inhibitors reduce polyglutamine toxicity. Proc. Natl Acad. Sci. USA 98 (2001) 15179-15184
67. McPhaul M.J., Marcelli M., Tilley W.D., Griffin J.E., and Wilson J.D. Androgen resistance caused by mutations in the androgen receptor gene. FASEB J 5 (1991) 2910-2915
68. Menard C.S., and Harlan R.E. Up-regulation of androgen receptor immunoreactivity in the rat brain by androgenic-anabolic steroids. Brain Res 622 (1993) 226-236
69. Meriggioli M.N., and Rowin J. Fatigue and abnormal neuromuscular transmission in Kennedy's disease. Muscle Nerve 27 (2003) 249-251
70. Mhatre A.N., Trifiro M.A., Kaufman M., Kazemi-Esfarjani P., Figlewicz D., Rouleau G., and Pinsky L. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat. Genet 5 (1993) 184-188
71. Nelson K.A., and Witte J.S. Androgen receptor CAG repeats and prostate cancer. Am. J. Epidemiol 155 (2002) 883-890
72. Nucifora Jr. F.C., Sasaki M., Peters M.F., Huang H., Cooper J.K., Yamada M., Takahashi H., Tsuji S., Troncoso J., Dawson V.L., Dawson T.M., and Ross C.A. Interference by huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science 291 (2001) 2423-2428
73. Okazawa H., Rich T., Chang A., Lin X., Waragai M., Kajikawa M., Enokido Y., Komuro A., Kato S., Shibata M., Hatanaka H., Mouradian M.M., Sudol M., and Kanazawa I. Interaction between mutant ataxin-1 and PQBP-1 affects transcription and cell death. Neuron 34 (2002) 701-713
74. Olney R.K., Aminoff M.J., and So Y.T. Clinical and electrodiagnostic features of X-linked recessive bulbospinal neuronopathy. Neurology 41 (1991) 823-828
75. Perutz M.F., Johnson T., Suzuki M., and Finch J.T. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl Acad. Sci. USA 91 (1994) 5355-5358
76. Polo A., Teatini F., D'Anna S., Manganotti P., Salviati A., Dallapiccola B., Zanette G., and Rizzuto N. Sensory involvement in X-linked spino-bulbar muscular atrophy (Kennedy's syndrome): an electrophysiological study. J. Neurol 243 (1996) 388-392
77. Pozzi P., Bendotti C., Simeoni S., Piccioni F., Guerini V., Marron T.U., Martini L., and Poletti A. Androgen 5-α-reductase type 2 is highly expressed and active in rat spinal cord motor neurones. J. Neuroendocrinol 15 (2003) 882-887
78. Puls I., Jonnakuty C., LaMonte B.H., Holzbaur E.L., Tokito M., Mann E., Floeter M.K., Bidus K., Drayna D., Oh S.J., Brown R.H., Ludlow C.L., and Fischbeck K.H. Mutant dynactin in motor neuron disease. Nat. Genet 33 (2003) 455-456
79. Sar M., and Stumpf W.E. Androgen concentration in motor neurons of cranial nerves and spinal cord. Science 197 (1977) 77-79
80. Saudou F., Finkbeiner S., Devys D., and Greenberg M.E. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95 (1998) 55-66
81. Schmidt B.J., Greenberg C.R., Allingham-Hawkins D.J., and Spriggs E.L. Expression of X-linked bulbospinal muscular atrophy (Kennedy disease) in two homozygous women. Neurology 59 (2002) 770-772
82. Shaw P.J., Thagesen H., Tomkins J., Slade J.Y., Usher P., Jackson A., Curtis A., Bushby K., and Ince P.G. Kennedy's disease: unusual molecular pathological and clinical features. Neurology 51 (1998) 252-255
83. Shibata N., Hirano A., Kobayashi M., Siddique T., Deng H.X., Hung W.Y., Kato T., and Asayama K. Intense superoxide dismutase-1 immunoreactivity in intracytoplasmic hyaline inclusions of familial amyotrophic lateral sclerosis with posterior column involvement. J. Neuropathol. Exp. Neurol 55 (1996) 481-490
84. Simerly R.B., Chang C., Muramatsu M., and Swanson L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol 294 (1990) 76-95
85. Sobue G., Hashizume Y., Mukai E., Hirayama M., Mitsuma T., and Takahashi A. X-linked recessive bulbospinal neuropathy. A clinicopathological study. Brain 112 (1989) 209-232
86. Sobue G., Doyu M., Kachi T., Yasuda T., Mukai E., Kumagai T., and Mitsuma T. Subclinical phenotypic expressions in heterozygous females of X-linked recessive bulbospinal neuronopathy. J. Neurol. Sci 117 (1993) 74-78
87. Sperfeld A.D., Karitzky J., Brummer D., Schreiber H., Haussler J., Ludolph A.C., and Hanemann C.O. X-linked bulbospinal neuronopathy: Kennedy Disease. Arch. Neurol 59 (2002) 1921-1926
88. Steffan J.S., Kazantsev A., Spasic-Boskovic O., Greenwald M., Zhu Y.Z., Gohler H., Wanker E.E., Bates G.P., Housman D.E., and Thompson L.M. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl Acad. Sci. USA 97 (2000) 6763-6768
89. Steffan J.S., Bodai L., Pallos J., Poelman M., McCampbell A., Apostol B.L., Kazantsev A., Schmidt E., Zhu Y.Z., Greenwald M., Kurokawa R., Housman D.E., Jackson G.R., Marsh J.L., and Thompson L.M. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. Nature 413 (2001) 739-743
90. Stenoien D.L., Cummings C.J., Adams H.P., Mancini M.G., Patel K., DeMartino G.N., Marcelli M., Weigel N.L., and Mancini M.A. Polyglutamine-expanded androgen receptors form aggregates that sequester heat shock proteins, proteasome components and SRC-1, and are suppressed by the HDJ-2 chaperone. Hum. Mol. Genet 8 (1999) 731-741
91. Sugars K.L., and Rubinsztein D.C. Transcriptional abnormalities in Huntington disease. Trends Genet 19 (2003) 233-238
92. Takeyama K., Ito S., Yamamoto A., Tanimoto H., Furutani T., Kanuka H., Miura M., Tabata T., and Kato S. Androgen-dependent neurodegeneration by polyglutamine-expanded human androgen receptor in Drosophila. Neuron 35 (2002) 855-864
93. Trojaborg W., and Wulff C.H. X-linked recessive bulbospinal neuronopathy (Kennedy's syndrome): a neurophysiological study. Acta Neurol. Scand 89 (1994) 214-219
94. Walcott J.L., and Merry D.E. Ligand promotes intranuclear inclusions in a novel cell model of spinal and bulbar muscular atrophy. J. Biol. Chem 277 (2002) 50855-50859
95. Weber M., and Eisen A. Assessment of upper and lower motor neurons in Kennedy's disease: implications for corticomotoneuronal PSTH studies. Muscle Nerve 22 (1999) 299-306
96. Wilde J., Moss T., and Thrush D. X-linked bulbo-spinal neuronopathy: a family study of three patients. J. Neurol. Neurosurg. Psychiatry 50 (1987) 279-284
97. Yu W.-H.A., and McGinnis M.Y. Androgen receptor levels in cranial nerve nuclei and tongue muscles in rats. J. Neurosci 6 (1986) 1302-1307
98. Yu W.-H.A., and Srinivasan R. Effect of testosterone and 5α-dihydrotestosterone on regeneration of the hypoglossal nerve in rats. Exp. Neurol 71 (1981) 431-435
99. 1A-voltage-dependent calcium channel. Nat. Genet 15 (1997) 62-69
100. Zoghbi H.Y., and Orr H.T. Glutamine repeats and neurodegeneration. Annu. Rev. Neurosci 23 (2000) 217-247
101. Zuccato C., Tartari M., Crotti A., Goffredo D., Valenza M., Conti L., Cataudella T., Leavitt B.R., Hayden M.R., Timmusk T., Rigamonti D., and Cattaneo E. Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet 35 (2003) 76-83